| 8/16/2024 | BKCVDDEMIGPV | Market Commentary: Junk closes heavy volume week, pipeline expected to dwindle; Prime Healthcare improves
|
| 7/9/2024 | BKCVDDEMIGPV | Market Commentary: Cinemark, Watco price; Brightline improves; Emergent jumps
|
| 2/16/2023 | BKCVDDEMIGPV | Market Commentary: Junk: CHS/Community Health active post-earnings; Service Properties, Emergent Bio jump
|
| 4/30/2021 | BKCVHY | Moody's alters Emergent view to negative
|
| 4/20/2021 | BKCVDDEMIGPV | Market Commentary: High yield: Morgan Automotive prices; Jazz megadeal on tap; Charter flat; Emergent down again
|
| 8/5/2020 | BKCVDDEMIGPV | Market Commentary: Howard Hughes, Harvest Midstream, DSLD price; new deals trade up; index turns positive
|
| 8/4/2020 | BKCVDDEMIGPV | Market Commentary: Leviathan, Penske, Emergent, Element, Xerox price; Melco adds on; Service, Apache gain
|
| 8/4/2020 | BKCVHY | Moody’s gives Emergent BioSolutions Ba2, notes Ba3
|
| 8/4/2020 | BKCVHY | S&P rates Emergent BioSolutions BB, notes BB-
|
| 11/15/2017 | CV | Market Commentary: Rambus eclipses Quotient in trades; Everbridge to price; Emergent dips; Acorda tanks
|
| 11/14/2017 | CVLM | Emergent BioSolutions to terminate conversion rights of 2.875% notes
|
| 8/12/2016 | CV | Emergent BioSolutions lowers conversion price of 2.875% convertibles
|
| 1/27/2014 | CV | Emergent greenshoe ups 2.875% seven-year convertibles to $250 million
|
| 1/24/2014 | CV | Market Commentary: Midday Commentary: Emergent BioSolutions up on hedge; Colony Financial 'still wrapped around 100'
|
| 1/24/2014 | CV | Market Commentary: New Emergent BioSolutions rises on hedge; International Game drops; Exterran sees sellers
|
| 1/23/2014 | CV | New Issue: Emergent prices $215 million seven-year convertibles at 2.875%, up 37.5%
|
| 1/23/2014 | CV | Market Commentary: New Colony mostly flat, old Colony 'comes in'; Emergent looks 'fine'; China names in focus
|
| 1/22/2014 | CV | Emergent BioSolutions offers $200 million seven-year convertibles at 2.625%-3.125%, up 27.5%-32.5%
|
| 1/22/2014 | CV | Market Commentary: Nuance flat to lower on swap after improved guidance; Colony Financial, Emergent on tap
|
| 5/3/2012 | CVIGPF | Emergent BioSolutions files $180 million stock, debt, preferreds shelf
|
| 11/12/2008 | CVIG | Emergent BioSolutions files $100 million shelf
|
